Related Experiment Video
Updated: May 1, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Evaluation and predictive factors of renal function progression using cystatin C and creatinine in neonates born with
Insights
Cystatin C (CysC) is a better marker than creatinine for monitoring kidney function in neonates with congenital anomalies of the kidney and urinary tract (CAKUT). Bilateralism and asymmetric relative renal function are linked to disease progression.
Area of Science:
- Pediatric Nephrology
- Biomarker Discovery
- Renal Function Assessment
Background:
- Congenital anomalies of the kidney and urinary tract (CAKUT) affect 1 in 500 pregnancies and are a leading cause of childhood end-stage renal disease.
- Currently, no validated early predictive markers exist for long-term renal function (RF) in neonates with CAKUT.
Purpose of the Study:
- To compare Cystatin C (CysC) and creatinine (creat) as markers of RF from birth to 2 years in neonates with CAKUT.
- To identify factors associated with RF progression in this population.
Main Methods:
- A cohort of 56 neonates with CAKUT was followed for a median of 235 days.
- Repeated measures of CysC and creat were taken over 2 years to analyze changes in RF with age.
- Potential risk factors including kidney disease type, bilateralism, prenatal pelvic dilatation, reflux, and initial relative RF asymmetry were assessed.
Main Results:
- Both CysC and creatinine showed a rapid decrease in the first month, followed by stabilization after one year.
- CysC demonstrated a significant decrease between 1 month and 1 year, while creatinine stabilized.
- Multivariate analysis revealed that CysC levels were significantly associated with bilateralism and asymmetric relative RF, whereas creatinine was not.
Conclusions:
- Cystatin C is a more effective biomarker than creatinine for monitoring renal function in neonates with CAKUT.
- Bilateralism and asymmetric relative renal function are significant predictors of RF progression in neonates with CAKUT, as identified by CysC.
Background:
Congenital anomalies of the kidney and urinary tract (CAKUT) is a main cause leading to endstage renal disease (ESRD) during childhood occurring at a frequency of 1 in every 500 pregnancies. No early predictive markers of long-term renal function (RF) are validated in these neonates. The aim of this study was to compare CysC and creatinine (creat) as markers of RF from birth to 2 years and to identify factors of RF progression.
Methods:
The 56 patients included in this study were followed for a median of 235 days (137 - 739). Repeated measures of CysC and creat during 2 years of RF evaluation were taken in 28 patients. Changes in RF with age were analyzed. Potential risk factors for RF progression were analyzed for: type of kidney disease (KD), bilateralism of KD, prenatal pelvic dilatation, reflux and initial relative RF (RRF) asymmetry obtained by scan.
Results:
With age, a rapid decrease of CysC (16.3%, p < 0.001), and creat (68.6%, p < 0.001) was observed at 1 month. Between 1 month and 1 year, CysC decreased 4% per month (p < 0.001) and creatinine stabilized (+ 1.9%/m, p = 0.11). After 1 year, both CysC and creat stabilized. In the multivariate model, CysC significantly increased in patients with bilateralism (p = 0.004) or asymmetric RRF (p = 0.03). Creat was not significant.
Conclusion:
CysC was a better marker than creat to follow RF in neonates with CAKUT. Using CysC, bilateralism, and RRF asymmetry were significantly associated with RF progression.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Chronic Kidney Disease I: Introduction

